Cassava Sciences, Inc.
SAVA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $129 | $121 | $201 | $233 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $1 | $1 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $7 | $8 | $10 | $11 |
| Total Curr. Assets | $137 | $130 | $211 | $244 |
| Property Plant & Equip (Net) | $21 | $22 | $23 | $21 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $1 | $1 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $21 | $22 | $24 | $22 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $158 | $152 | $235 | $267 |
| Liabilities | – | – | – | – |
| Payables | $8 | $11 | $4 | $7 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $4 | $4 | $3 | $5 |
| Total Curr. Liab. | $12 | $14 | $7 | $13 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $12 | $14 | $7 | $13 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$405 | -$381 | -$284 | -$207 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $551 | $518 | $511 | $461 |
| Total Equity | $146 | $137 | $228 | $254 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $158 | $152 | $235 | $267 |
| Net Debt | -$129 | -$121 | -$201 | -$233 |